International Journal of Clinical Case Reports, 2025, Vol.15, No.5, 228-238 http://medscipublisher.com/index.php/ijccr 237 Khanna N., Klyushnenkova E., Zhan M., Jeong D., Kernan C., and Stewart D., 2023, Characterization of the COVID-19 vaccine uptake in patients with chronic diseases in a large university-based family medicine clinical practice, Journal of Primary Care and Community Health, 14: 21501319231175369. https://doi.org/10.1177/21501319231175369 Li C.X., 2024, New hope in transplantation medicine: the role of mesenchymal stem cells in the prevention and treatment of GVHD, International Journal of Molecular Medical Science, 14(3): 167-176. https://doi.org/10.5376/ijmms.2024.14.0020 Li Z., Liu S., Li F., Li Y., Li Y., Peng P., Li S., He L., and Liu T., 2022, Efficacy immunogenicity and safety of COVID-19 vaccines in older adults: a systematic review and meta-analysis, Frontiers in Immunology, 13: 965971. https://doi.org/10.3389/fimmu.2022.965971 Liu S., Jiang C., Liu Y., Qiu X., Luo J., Wang J., and Xu Y., 2024, Covid-19 vaccination coverage and associated factors among older hypertensive patients in Hangzhou China., International Health, 17: 62-70. https://doi.org/10.1093/inthealth/ihae019 Liu S., Jiang C., Wang J., and Liu Y., 2023, The factors correlated with COVID-19 vaccination coverage in Chinese hypertensive patients managed by community general practitioner, Human Vaccines and Immunotherapeutics, 19(1): 2197839. https://doi.org/10.1080/21645515.2023.2197839 Lokendra S., Tiwari S., Anil B., Monika R., Aditya S., Smita J., and Madhav A., 2021, Active surveillance of adverse events following coronavirus disease 2019 immunization in the elderly population: a prospective multi-centric study from Jaipur Rajasthan India, Journal of the Indian Academy of Geriatrics, 17(3): 83-88. https://doi.org/10.4103/jiag.jiag_20_21 Ma X.L., Qin L.L., He C.Y., and Huang Y.L., 2025, Study on the application of AI-assisted diagnostic systems in emergency care for patients with cerebrovascular accidents, International Journal of Clinical Case Reports, 15(3): 98-109. https://doi.org/10.5376/ijccr.2025.15.0011 Marsh E., Kornberg M., Kessler K., Haq I., Patel A., Nath A., Schierman B., and Jones L., 2021, COVID-19 and vaccination in the setting of neurologic disease, Neurology, 97: 720-728. https://doi.org/10.1212/wnl.0000000000012578 Montano D., 2022, Frequency and associations of adverse reactions of COVID-19 vaccines reported to pharmacovigilance systems in the European Union and the United States, Frontiers in Public Health, 9: 756633. https://doi.org/10.3389/fpubh.2021.756633 Müller L., Andrée M., Moskorz W., Drexler I., Hauka S., Ptok J., Walotka L., Grothmann R., Hillebrandt J., Ritchie A., Peter L., Walker A., Timm J., Adams O., and Schaal H., 2022, Adjusted booster schedules disperse age-dependent differences in antibody titers benefitting risk populations, medRxiv, (2022): 2022-08. https://doi.org/10.1101/2022.08.08.22278545 Mwimanzi F., Lapointe H., Cheung P., Sang Y., Yaseen F., Umviligihozo G., Kalikawe R., Datwani S., Omondi F., Burns L., Young L., Leung V., Agafitei O., Ennis S., Dong W., Basra S., Lim L., Ng K., Pantophlet R., Brumme C., Montaner J., Prystajecky N., Lowe C., DeMarco M., Holmes D., Simons J., Niikura M., Romney M., Brumme Z., and Brockman M., 2022, Older adults mount less durable humoral responses to two doses of COVID-19 mRNA vaccine but strong initial responses to a third dose, The Journal of Infectious Diseases, 226: 983-994. https://doi.org/10.1093/infdis/jiac199 Notarte K., Ver A., Velasco J., Pastrana A., Catahay J., Salvagno G., Yap E., Martínez-Sobrido L., Torrelles J., Lippi G., and Henry B., 2021, Effects of age sex serostatus and underlying comorbidities on humoral response post-SARS-CoV-2 Pfizer-BioNTech mRNA vaccination: a systematic review, Critical Reviews in Clinical Laboratory Sciences, 59(6): 373-390. https://doi.org/10.1080/10408363.2022.2038539 Okuyama R., 2023, mRNA and adenoviral vector vaccine platforms utilized in COVID-19 vaccines: technologies ecosystem and future directions, Vaccines, 11(12): 1737. https://doi.org/10.3390/vaccines11121737 Patone M., Mei X., Handunnetthi L., Dixon S., Zaccardi F., Shankar-Hari M., Watkinson P., Khunti K., Harnden A., Coupland C., Channon K., Mills N., Sheikh A., and Hippisley-Cox J., 2021, Risks of myocarditis pericarditis and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection, Nature Medicine, 28: 410-422. https://doi.org/10.1038/s41591-021-01630-0 Rotshild V., Hirsh-Raccah B., Miskin I., Muszkat M., and Matok I., 2021, Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis, Scientific Reports, 11(1): 22777. Şahin U., Muik A., Derhovanessian E., Vogler I., Kranz L., Vormehr M., Baum A., Pascal K., Quandt J., Maurus D., Brachtendorf S., Lörks V., Sikorski J., Hilker R., Becker D., Eller A., Grützner J., Boesler C., Rosenbaum C., Kühnle M., Luxemburger U., Kemmer-Brück A., Langer D., Bexon M., Bolte S., Karikó K., Palanché T., Fischer B., Schultz A., Shi P., Fontes-Garfias C., Perez J., Swanson K., Loschko J., Scully I., Cutler M., Kalina W., Kyratsous C., Cooper D., Dormitzer P., Jansen K., and Türeci Ö., 2020, COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses, Nature, 586(7830): 594-599. https://doi.org/10.1038/s41586-020-2814-7 Shapovalova V., 2022, An innovative multidisciplinary study of the availability of coronavirus vaccines in the world, SSP Modern Pharmacy and Medicine, 2(2): 1-7.
RkJQdWJsaXNoZXIy MjQ4ODYzNA==